HomeKLRS • NASDAQ
add
Kalaris Therapeutics Inc
Previous close
$5.92
Day range
$5.87 - $6.27
Year range
$2.14 - $12.82
Market cap
112.78M USD
Avg Volume
139.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.74M | -66.34% |
Net income | -11.89M | 68.77% |
Net profit margin | — | — |
Earnings per share | -0.64 | — |
EBITDA | -12.74M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 77.00M | 3,925.04% |
Total assets | 81.18M | 3,198.46% |
Total liabilities | 39.31M | -14.25% |
Total equity | 41.86M | — |
Shares outstanding | 18.70M | — |
Price to book | 2.64 | — |
Return on assets | -36.61% | — |
Return on capital | -66.00% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -11.89M | 68.77% |
Cash from operations | -11.33M | -161.91% |
Cash from investing | -34.71M | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -46.04M | -964.24% |
Free cash flow | -7.43M | — |
About
Founded
2019
Headquarters
Website
Employees
14
